GLFinancial Services · Insurance - LifeThe 11 Wall Street analysts covering Globe Life, Inc. hold a median 12-month price target of $182 — +12.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 51 of 100 as at 3 Nov 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Globe Life, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (82): The shares have been drifting up relative to others.
Accruals (37): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on GL, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +12.6% from it.
Of the 20 most recent actions, 6 moved their price target up and 6 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 Oct 2026 | Wells Fargo | Maintains | Overweight | $191 → $180 |
| 23 Oct 2026 | Evercore ISI Group | Maintains | In-Line | $176 → $174 |
| 23 Oct 2026 | Piper Sandler | Downgrade | Neutral | $200 → $165 |
| 23 Oct 2026 | TD Cowen | Maintains | Buy | $225 → $215 |
| 15 Oct 2026 | JP Morgan | Maintains | Overweight | — |
| 15 Oct 2026 | JP Morgan | Maintains | Overweight | $193 → $195 |
| 12 Oct 2026 | Wells Fargo | Maintains | Overweight | $190 → $191 |
| 12 Oct 2026 | Wells Fargo | Maintains | Overweight | — |
| 5 Oct 2026 | Morgan Stanley | Maintains | Overweight | $208 → $197 |
| 5 Oct 2026 | Morgan Stanley | Maintains | Overweight | — |
| 24 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $192 → $190 |
| 24 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 22 July 2026 | TD Cowen | Maintains | Buy | $215 → $225 |
| 22 July 2026 | TD Cowen | Maintains | Buy | — |
| 21 July 2026 | JP Morgan | Maintains | Overweight | — |
| 21 July 2026 | JP Morgan | Maintains | Overweight | $181 → $201 |
| 15 July 2026 | Piper Sandler | Maintains | Overweight | $175 → $200 |
| 15 July 2026 | Piper Sandler | Maintains | Overweight | — |
| 13 July 2026 | Evercore ISI Group | Maintains | In-Line | $157 → $176 |
| 13 July 2026 | Evercore ISI Group | Maintains | In-Line | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
GL appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Globe Life, Inc. returned +22.2% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 56% of US stocks
Cheaper than 52% of US stocks
Cheaper than 43% of US stocks
Cheaper than 40% of US stocks
Higher than 41% of US stocks
Higher than 29% of US stocks
Higher than 87% of US stocks
Higher than 81% of US stocks
Higher than 80% of US stocks
Higher than 70% of US stocks
Higher than 69% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Globe Life, Inc. has a market value of $12.4B and an enterprise value of $15.1B.
Revenue in the twelve months to 30 June 2026: $6.2B. The latest quarter grew 5.5% year on year.
Net income over the same four quarters: $1.2B, a 19.6% net margin.
Diluted earnings per share, trailing twelve months: $15.06.
Free cash flow in the twelve months to 30 June 2026: $1.2B.
Globe Life, Inc. spent $881.3M on share buybacks and $90.6M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 10.9×; forward P/E: 9.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.82%, paying out 8% of earnings.
Globe Life, Inc. employs 3,695 people — $1.7M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Globe Life, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The Motley Fool highlighted management’s expectation of $850 million to $950 million in excess cash flow in 2027 and Globe Life’s $185 million stock repurchase in the third quarter.
Why it matters — These figures provide GL watchers with information about the company’s expected cash flow and recent share repurchases.
PRNewsWire published a notice asking Globe Life shareholders to contact a firm to discuss their rights and options regarding alleged insider breaches of fiduciary duties. The firm states it would handle any matter on a contingent-fee basis, with no out-of-pocket legal fees or expenses for shareholders.
Why it matters — The notice raises allegations of potential fiduciary-duty breaches involving Globe Life insiders, which may be relevant to shareholders monitoring the company.
Globe Life disclosed roughly $7 million in excess prior-period Medicare Supplement claims linked to a federal CMS processing delay. GL shares fell over 8%, and SueWallSt announced an investigation into what investors were told about the company's exposure to CMS claims processing.
Why it matters — The investigation focuses on disclosures about GL's exposure to CMS claims-processing issues, alongside the reported claims and share decline.
Globe Life held its Q3 2026 earnings call on October 22, 2026. The excerpt lists company executives and analysts participating but does not include earnings results or management commentary.
Why it matters — The call is a source of quarterly information for GL watchers, though the supplied excerpt provides no performance details.
Globe Life reported third-quarter net income of $361 million, or $4.62 per share, down 2% from a year earlier. Net operating income increased 1% to $379 million, or $4.84 per share, compared with $4.81 in the prior-year quarter.
Why it matters — The results show contrasting year-over-year movements in Globe Life’s net income and net operating income.
The 11 Wall Street analysts covering Globe Life, Inc. have a median 12-month price target of $182, with estimates ranging from $161 to $215. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering Globe Life, Inc., 7 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Globe Life, Inc. 51 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, Globe Life, Inc. ranks 51 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (82 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies +12.6% from the last close, and Ticker Nerd's factor model ranks Globe Life, Inc. 51 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Globe Life, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for GL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $161 to $215 over the next 12 months.
Globe Life, Inc. returned +22.2% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Globe Life Inc. is a financial services holding company that provides life insurance, supplemental health insurance, and annuity products through its subsidiaries.
The most recent item we track (The Motley Fool, 30 Oct 2026): "Globe Life: 3 Key Takeaways for Long-Term Investors". The Motley Fool highlighted management’s expectation of $850 million to $950 million in excess cash flow in 2027 and Globe Life’s $185 million stock repurchase in the third quarter.
Globe Life Inc. is a financial services holding company that provides life insurance, supplemental health insurance, and annuity products through its subsidiaries. Globe Life Inc. serves individuals and families across the United States with coverage designed to address everyday protection needs, including whole life, term life, Medicare supplement, accident, cancer, critical illness, and other limited-benefit health policies. The company also offers related investment activities as part of its overall insurance operations. Its business is organized around core insurance segments that support direct-to-consumer sales, independent agents, and other distribution channels. Headquartered in McKinney, Texas, Globe Life Inc. focuses on accessible protection products for mass-market customers and plays a steady role in the U.S. insurance sector by providing policy-based financial security and supplemental coverage.
CEO Mr. Frank Martin Svoboda · 3,695 employees · United States · https://home.globelifeinsurance.com
